| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| QDEL - Quidel Corporation | HOLD | 0 @ USD 26.53 | USD 0 | The current share valuation price of QDEL based on adjusted close was USD 26.53. The average price that QDEL shares were previous bought at was USD 34.337. The current market price is -22.7% lower than average price they were purchased at. The value of the holding in QDEL has increased by USD 476 compared to the previous valuation of Quidel Corporation however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| LMAT - LeMaitre Vascular Inc | HOLD | 0 @ USD 83.68 | USD 0 | The current share valuation price of LMAT based on adjusted close was USD 83.68. The average price that LMAT shares were previous bought at was USD 88.5551. The current market price is -5.5% lower than average price they were purchased at. The value of the holding in LMAT has increased by USD 2,599 compared to the previous valuation of LeMaitre Vascular Inc however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| MASI - Masimo Corporation | HOLD | 0 @ USD 142.19 | USD 0 | The current share valuation price of MASI based on adjusted close was USD 142.19. The average price that MASI shares were previous bought at was USD 154.973. The current market price is -8.2% lower than average price they were purchased at. The value of the holding in MASI has fallen by USD 11,752 compared to the previous valuation of Masimo Corporation |
| MDT - Medtronic PLC | HOLD | 0 @ USD 102.03 | USD 0 | The current share valuation price of MDT based on adjusted close was USD 102.03. The average price that MDT shares were previous bought at was USD 89.4904. The current market price is 14.0% higher than average price they were purchased at. The value of the holding in MDT has fallen by USD 233,797 compared to the previous valuation of Medtronic PLC |
| NVCR - Novocure Ltd | HOLD | 0 @ USD 10.92 | USD 0 | The current share valuation price of NVCR based on adjusted close was USD 10.92. The average price that NVCR shares were previous bought at was USD 17.8097. The current market price is -38.7% lower than average price they were purchased at. The value of the holding in NVCR has fallen by USD 10,790 compared to the previous valuation of Novocure Ltd |
| NVST - Envista Holdings Corp | HOLD | 0 @ USD 20.18 | USD 0 | The current share valuation price of NVST based on adjusted close was USD 20.18. The average price that NVST shares were previous bought at was USD 19.1276. The current market price is 5.5% higher than average price they were purchased at. The value of the holding in NVST has fallen by USD 13,827 compared to the previous valuation of Envista Holdings Corp |
| OFIX - Orthofix Medical Inc | HOLD | 0 @ USD 15.72 | USD 0 | The current share valuation price of OFIX based on adjusted close was USD 15.72. The average price that OFIX shares were previous bought at was USD 15.4031. The current market price is 2.1% higher than average price they were purchased at. The value of the holding in OFIX has fallen by USD 720 compared to the previous valuation of Orthofix Medical Inc |
| OMCL - Omnicell Inc | HOLD | 0 @ USD 38.46 | USD 0 | The current share valuation price of OMCL based on adjusted close was USD 38.46. The average price that OMCL shares were previous bought at was USD 34.6291. The current market price is 11.1% higher than average price they were purchased at. The value of the holding in OMCL has increased by USD 15,138 compared to the previous valuation of Omnicell Inc however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| PEN - Pennant International Group plc | HOLD | 0 @ USD 287.71 | USD 0 | The current share valuation price of PEN based on adjusted close was USD 287.71. The average price that PEN shares were previous bought at was USD 259.671. The current market price is 10.8% higher than average price they were purchased at. The value of the holding in PEN has fallen by USD 21,539 compared to the previous valuation of Pennant International Group plc |
| PEN - PBF Energy Inc | HOLD | 0 @ USD 287.71 | USD 0 | The current share valuation price of PEN based on adjusted close was USD 287.71. The average price that PEN shares were previous bought at was USD 259.671. The current market price is 10.8% higher than average price they were purchased at. The value of the holding in PEN has fallen by USD 21,539 compared to the previous valuation of PBF Energy Inc |
| PODD - Insulet Corporation | HOLD | 0 @ USD 309 | USD 0 | The current share valuation price of PODD based on adjusted close was USD 309. The average price that PODD shares were previous bought at was USD 293.253. The current market price is 5.4% higher than average price they were purchased at. The value of the holding in PODD has fallen by USD 17,952 compared to the previous valuation of Insulet Corporation |
| PRCT - Procept Biorobotics Corp | HOLD | 0 @ USD 29.53 | USD 0 | The current share valuation price of PRCT based on adjusted close was USD 29.53. The average price that PRCT shares were previous bought at was USD 59.3385. The current market price is -50.2% lower than average price they were purchased at. The value of the holding in PRCT has fallen by USD 6,784 compared to the previous valuation of Procept Biorobotics Corp |
| LIVN - LivaNova PLC | HOLD | 0 @ USD 63.68 | USD 0 | The current share valuation price of LIVN based on adjusted close was USD 63.68. The average price that LIVN shares were previous bought at was USD 46.7757. The current market price is 36.1% higher than average price they were purchased at. The value of the holding in LIVN has increased by USD 4,271 compared to the previous valuation of LivaNova PLC however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| RMD - ResMed Inc | HOLD | 0 @ USD 250.85 | USD 0 | The current share valuation price of RMD based on adjusted close was USD 250.85. The average price that RMD shares were previous bought at was USD 244.874. The current market price is 2.4% higher than average price they were purchased at. The value of the holding in RMD has increased by USD 50,432 compared to the previous valuation of ResMed Inc however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| SIBN - Si-Bone Inc | HOLD | 0 @ USD 19.42 | USD 0 | The current share valuation price of SIBN based on adjusted close was USD 19.42. The average price that SIBN shares were previous bought at was USD 15.3583. The current market price is 26.4% higher than average price they were purchased at. The value of the holding in SIBN has increased by USD 2,798 compared to the previous valuation of Si-Bone Inc however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| STE - STERIS plc | HOLD | 0 @ USD 259.3 | USD 0 | The current share valuation price of STE based on adjusted close was USD 259.3. The average price that STE shares were previous bought at was USD 229.731. The current market price is 12.9% higher than average price they were purchased at. The value of the holding in STE has fallen by USD 49,168 compared to the previous valuation of STERIS plc |
| SYK - Stryker Corporation | HOLD | 0 @ USD 366.68 | USD 0 | The current share valuation price of SYK based on adjusted close was USD 366.68. The average price that SYK shares were previous bought at was USD 374.8. The current market price is -2.2% lower than average price they were purchased at. The value of the holding in SYK has fallen by USD 270,309 compared to the previous valuation of Stryker Corporation |
| TFX - Teleflex Incorporated | HOLD | 0 @ USD 116.17 | USD 0 | The current share valuation price of TFX based on adjusted close was USD 116.17. The average price that TFX shares were previous bought at was USD 142.319. The current market price is -18.4% lower than average price they were purchased at. The value of the holding in TFX has increased by USD 10,813 compared to the previous valuation of Teleflex Incorporated however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| TMCI - Treace Medical Concepts Inc | HOLD | 0 @ USD 2.70005 | USD 0 | The current share valuation price of TMCI based on adjusted close was USD 2.70005. The average price that TMCI shares were previous bought at was USD 7.60423. The current market price is -64.5% lower than average price they were purchased at. The value of the holding in TMCI has fallen by USD 782 compared to the previous valuation of Treace Medical Concepts Inc |
| TMDX - TransMedics Group Inc | HOLD | 0 @ USD 141.77 | USD 0 | The current share valuation price of TMDX based on adjusted close was USD 141.77. The average price that TMDX shares were previous bought at was USD 93.1357. The current market price is 52.2% higher than average price they were purchased at. The value of the holding in TMDX has fallen by USD 41,009 compared to the previous valuation of TransMedics Group Inc |
| TNDM - Tandem Diabetes Care Inc | HOLD | 0 @ USD 19.62 | USD 0 | The current share valuation price of TNDM based on adjusted close was USD 19.62. The average price that TNDM shares were previous bought at was USD 20.954. The current market price is -6.4% lower than average price they were purchased at. The value of the holding in TNDM has fallen by USD 8,612 compared to the previous valuation of Tandem Diabetes Care Inc |
| VREX - Varex Imaging Corp | HOLD | 0 @ USD 11.33 | USD 0 | The current share valuation price of VREX based on adjusted close was USD 11.33. The average price that VREX shares were previous bought at was USD 11.354. The current market price is -0.2% lower than average price they were purchased at. The value of the holding in VREX has fallen by USD 1,051 compared to the previous valuation of Varex Imaging Corp |
| ZBH - Zimmer Biomet Holdings Inc | HOLD | 0 @ USD 94.14 | USD 0 | The current share valuation price of ZBH based on adjusted close was USD 94.14. The average price that ZBH shares were previous bought at was USD 102.164. The current market price is -7.9% lower than average price they were purchased at. The value of the holding in ZBH has fallen by USD 17,153 compared to the previous valuation of Zimmer Biomet Holdings Inc |
| EW - Edwards Lifesciences Corp | HOLD | 0 @ USD 84.71 | USD 0 | The current share valuation price of EW based on adjusted close was USD 84.71. The average price that EW shares were previous bought at was USD 73.2429. The current market price is 15.7% higher than average price they were purchased at. The value of the holding in EW has fallen by USD 45,775 compared to the previous valuation of Edwards Lifesciences Corp |
| AORT - Artivion Inc | HOLD | 0 @ USD 45.37 | USD 0 | The current share valuation price of AORT based on adjusted close was USD 45.37. The average price that AORT shares were previous bought at was USD 34.7351. The current market price is 30.6% higher than average price they were purchased at. The value of the holding in AORT has fallen by USD 2,656 compared to the previous valuation of Artivion Inc |
| ATEC - Alphatec Holdings Inc | HOLD | 0 @ USD 21.17 | USD 0 | The current share valuation price of ATEC based on adjusted close was USD 21.17. The average price that ATEC shares were previous bought at was USD 13.2192. The current market price is 60.1% higher than average price they were purchased at. The value of the holding in ATEC has fallen by USD 12,519 compared to the previous valuation of Alphatec Holdings Inc |
| ATRC - AtriCure Inc | HOLD | 0 @ USD 35.31 | USD 0 | The current share valuation price of ATRC based on adjusted close was USD 35.31. The average price that ATRC shares were previous bought at was USD 35.4391. The current market price is -0.4% lower than average price they were purchased at. The value of the holding in ATRC has increased by USD 1,517 compared to the previous valuation of AtriCure Inc however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| AXGN - Axogen Inc | HOLD | 0 @ USD 27.69 | USD 0 | The current share valuation price of AXGN based on adjusted close was USD 27.69. The average price that AXGN shares were previous bought at was USD 18.2722. The current market price is 51.5% higher than average price they were purchased at. The value of the holding in AXGN has fallen by USD 5,536 compared to the previous valuation of Axogen Inc |
| BAX - Baxter International Inc | HOLD | 0 @ USD 18.84 | USD 0 | The current share valuation price of BAX based on adjusted close was USD 18.84. The average price that BAX shares were previous bought at was USD 27.4613. The current market price is -31.4% lower than average price they were purchased at. The value of the holding in BAX has fallen by USD 17,118 compared to the previous valuation of Baxter International Inc |
| BDX - Becton Dickinson and Company | HOLD | 0 @ USD 190.47 | USD 0 | The current share valuation price of BDX based on adjusted close was USD 190.47. The average price that BDX shares were previous bought at was USD 201.916. The current market price is -5.7% lower than average price they were purchased at. The value of the holding in BDX has fallen by USD 53,900 compared to the previous valuation of Becton Dickinson and Company |
| BSX - Boston Scientific Corporation | HOLD | 0 @ USD 99.02 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 99.02. The average price that BSX shares were previous bought at was USD 98.196. The current market price is 0.8% higher than average price they were purchased at. The value of the holding in BSX has fallen by USD 410,730 compared to the previous valuation of Boston Scientific Corporation |
| BSX - MULSTRXSSXIMETFP | HOLD | 0 @ USD 99.02 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 99.02. The average price that BSX shares were previous bought at was USD 98.196. The current market price is 0.8% higher than average price they were purchased at. The value of the holding in BSX has fallen by USD 410,730 compared to the previous valuation of MULSTRXSSXIMETFP |
| CNMD - CONMED Corporation | HOLD | 0 @ USD 44.03 | USD 0 | The current share valuation price of CNMD based on adjusted close was USD 44.03. The average price that CNMD shares were previous bought at was USD 56.641. The current market price is -22.3% lower than average price they were purchased at. The value of the holding in CNMD has fallen by USD 2,002 compared to the previous valuation of CONMED Corporation |
| DXCM - DexCom Inc | HOLD | 0 @ USD 64.45 | USD 0 | The current share valuation price of DXCM based on adjusted close was USD 64.45. The average price that DXCM shares were previous bought at was USD 75.1618. The current market price is -14.3% lower than average price they were purchased at. The value of the holding in DXCM has increased by USD 50,704 compared to the previous valuation of DexCom Inc however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| ENOV - Enovis Corp | HOLD | 0 @ USD 29.38 | USD 0 | The current share valuation price of ENOV based on adjusted close was USD 29.38. The average price that ENOV shares were previous bought at was USD 36.4594. The current market price is -19.4% lower than average price they were purchased at. The value of the holding in ENOV has increased by USD 161 compared to the previous valuation of Enovis Corp however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| ABT - Abbott Laboratories | HOLD | 0 @ USD 126.32 | USD 0 | The current share valuation price of ABT based on adjusted close was USD 126.32. The average price that ABT shares were previous bought at was USD 128.644. The current market price is -1.8% lower than average price they were purchased at. The value of the holding in ABT has fallen by USD 409,711 compared to the previous valuation of Abbott Laboratories |
| GEHC - GE HealthCare Technologies Inc. | HOLD | 0 @ USD 80.22 | USD 0 | The current share valuation price of GEHC based on adjusted close was USD 80.22. The average price that GEHC shares were previous bought at was USD 74.8934. The current market price is 7.1% higher than average price they were purchased at. The value of the holding in GEHC has increased by USD 62,407 compared to the previous valuation of GE HealthCare Technologies Inc. however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| GKOS - Glaukos Corp | HOLD | 0 @ USD 106.07 | USD 0 | The current share valuation price of GKOS based on adjusted close was USD 106.07. The average price that GKOS shares were previous bought at was USD 106.937. The current market price is -0.8% lower than average price they were purchased at. The value of the holding in GKOS has fallen by USD 318 compared to the previous valuation of Glaukos Corp |
| GMED - Globus Medical | HOLD | 0 @ USD 89.03 | USD 0 | The current share valuation price of GMED based on adjusted close was USD 89.03. The average price that GMED shares were previous bought at was USD 70.2905. The current market price is 26.7% higher than average price they were purchased at. The value of the holding in GMED has fallen by USD 11,959 compared to the previous valuation of Globus Medical |
| HOLX - Hologic Inc | HOLD | 0 @ USD 74.82 | USD 0 | The current share valuation price of HOLX based on adjusted close was USD 74.82. The average price that HOLX shares were previous bought at was USD 67.0007. The current market price is 11.7% higher than average price they were purchased at. The value of the holding in HOLX has fallen by USD 619 compared to the previous valuation of Hologic Inc |
| IART - Integra LifeSciences Holdings | HOLD | 0 @ USD 13.16 | USD 0 | The current share valuation price of IART based on adjusted close was USD 13.16. The average price that IART shares were previous bought at was USD 17.8768. The current market price is -26.4% lower than average price they were purchased at. The value of the holding in IART has increased by USD 927 compared to the previous valuation of Integra LifeSciences Holdings however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| IDXX - IDEXX Laboratories Inc | HOLD | 0 @ USD 732.73 | USD 0 | The current share valuation price of IDXX based on adjusted close was USD 732.73. The average price that IDXX shares were previous bought at was USD 509.311. The current market price is 43.9% higher than average price they were purchased at. The value of the holding in IDXX has increased by USD 41,905 compared to the previous valuation of IDEXX Laboratories Inc however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| INSP - Inspirit Energy Holdings Plc | HOLD | 0 @ USD 133.93 | USD 0 | The current share valuation price of INSP based on adjusted close was USD 133.93. The average price that INSP shares were previous bought at was USD 135.25. The current market price is -1.0% lower than average price they were purchased at. The value of the holding in INSP has increased by USD 28,394 compared to the previous valuation of Inspirit Energy Holdings Plc however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| IRTC - iRhythm Technologies Inc | HOLD | 0 @ USD 181.87 | USD 0 | The current share valuation price of IRTC based on adjusted close was USD 181.87. The average price that IRTC shares were previous bought at was USD 129.4. The current market price is 40.5% higher than average price they were purchased at. The value of the holding in IRTC has fallen by USD 3,897 compared to the previous valuation of iRhythm Technologies Inc |
| ISRG - Intuitive Surgical Inc | HOLD | 0 @ USD 567.72 | USD 0 | The current share valuation price of ISRG based on adjusted close was USD 567.72. The average price that ISRG shares were previous bought at was USD 510.011. The current market price is 11.3% higher than average price they were purchased at. The value of the holding in ISRG has increased by USD 17,477 compared to the previous valuation of Intuitive Surgical Inc however if the holding was sold on 2025-12-02 this would crystalise an overall loss. |
| ITGR - Integer Holdings Corp | HOLD | 0 @ USD 69.9899 | USD 0 | The current share valuation price of ITGR based on adjusted close was USD 69.9899. The average price that ITGR shares were previous bought at was USD 117.637. The current market price is -40.5% lower than average price they were purchased at. The value of the holding in ITGR has fallen by USD 8,538 compared to the previous valuation of Integer Holdings Corp |